Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia

Journal of Experimental Medicine

Volumn 210, Issue 6, 2013, Pages 1137-1151

  Roberts, Edward W ^a,d   Deonarine, Andrew ^e   Jones, James O ^a,d   Denton, Alice E ^a,d   Feig, Christine ^d   Lyons, Scott K ^d   Espeli, Marion ^b   Kraman, Matthew ^a,d   McKenna, Brendan ^a   Wells, Richard J B ^a,d   Zhao, Qi ^f   Caballero, Otavia L ^f   Larder, Rachel ^c   Coll, Anthony P ^c   O'Rahilly, Stephen ^c   Brindle, Kevin M ^d   Teichmann, Sarah A ^e   Tuveson, David A ^d,g   Fearon, Douglas T ^a,d  

^a Department of Medicine ^*  (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLLISTATIN; SEPRASE;

ADIPOSE TISSUE; ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CACHEXIA; CONTROLLED STUDY; ERYTHROPOIESIS; HEMATOPOIESIS; IMMUNOSURVEILLANCE; LYMPHOPOIESIS; MOUSE; MUSCLE MASS; NONHUMAN; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; SKELETAL MUSCLE; STROMA CELL; TRANSGENIC MOUSE;

ADIPOSE TISSUE; ANEMIA; ANIMALS; BONE MARROW; CACHEXIA; CELL LINEAGE; CHEMOKINE CXCL12; ERYTHROPOIESIS; FOLLISTATIN; GELATINASES; HEMATOPOIESIS; LYMPHOPOIESIS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUSCULAR DISORDERS, ATROPHIC; NEOPLASMS; PANCREAS; SERINE ENDOPEPTIDASES; STROMAL CELLS; TRANSCRIPTOME;

EID: 84880687861     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20122344     Document Type: Article

References (55)

1. Acharyya, S., M.E. Butchbach, Z. Sahenk, H. Wang, M. Saji, M. Carathers, M.D. Ringel, R.J. Skipworth, K.C. Fearon, M.A. Hollingsworth, et al. 2005. Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell. 8:421-432. http://dx.doi.org/10.1016/j.ccr.2005.10.004
2. Aertgeerts, K., I. Levin, L. Shi, G.P. Snell, A. Jennings, G.S. Prasad, Y. Zhang, M.L. Kraus, S. Salakian, V. Sridhar, et al. 2005. Structural and kinetic analysis of the substrate specificity of human fibroblast activation protein alpha. J. Biol. Chem. 280:19441-19444. http://dx.doi.org/10.1074/jbc. C500092200
3. Bauer, S., M.C. Jendro, A. Wadle, S. Kleber, F. Stenner, R. Dinser, A. Reich, E. Faccin, S. Gödde, H. Dinges, et al. 2006. Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res. Ther. 8:R171. http://dx.doi.org/10.1186/ar2080
4. Benny Klimek, M.E., T. Aydogdu, M.J. Link, M. Pons, L.G. Koniaris, and T.A. Zimmers. 2010. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia. Biochem. Biophys. Res. Commun. 391:1548-1554. http://dx.doi.org/10.1016/j.bbrc.2009.12.123
5. Bodine, S.C., E. Latres, S. Baumhueter, V.K. Lai, L. Nunez, B.A. Clarke, W.T. Poueymirou, F.J. Panaro, E. Na, K. Dharmarajan, et al. 2001. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 294:1704-1708. http://dx.doi.org/10.1126/science.1065874
6. Brokopp, C.E., R. Schoenauer, P. Richards, S. Bauer, C. Lohmann, M.Y. Emmert, B. Weber, S. Winnik, E. Aikawa, K. Graves, et al. 2011. Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata. Eur. Heart J. 32:2713-2722. http://dx.doi.org/10.1093/eurheartj/ehq519
7. Brown, M.L., L. Bonomi, N. Ungerleider, J. Zina, F. Kimura, A. Mukherjee, Y. Sidis, and A. Schneyer. 2011. Follistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis. Obesity (Silver Spring). 19:1940-1949. http://dx.doi.org/10.1038/oby.2011.97
8. Carmignac, V., R. Quéré, and M. Durbeej. 2011. Proteasome inhibition improves the muscle of laminin α2 chain-deficient mice. Hum. Mol. Genet. 20:541-552. http://dx.doi.org/10.1093/hmg/ddq499
9. Chang, H.Y., J.T. Chi, S. Dudoit, C. Bondre, M. van de Rijn, D. Botstein, and P.O. Brown. 2002. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc. Natl. Acad. Sci. USA. 99:12877-12882. http://dx.doi.org/10.1073/pnas.162488599
10. Coll, A.P., I.S. Farooqi, and S. O'Rahilly. 2007. The hormonal control of food intake. Cell. 129:251-262. http://dx.doi.org/10.1016/j.cell.2007.04.001
11. Costelli, P., M. Muscaritoli, A. Bonetto, F. Penna, P. Reffo, M. Bossola, G. Bonelli, G.B. Doglietto, F.M. Baccino, and F. Rossi Fanelli. 2008. Muscle myostatin signalling is enhanced in experimental cancer cachexia. Eur. J. Clin. Invest. 38:531-538. http://dx.doi.org/10.1111/j.1365-2362.2008.01970.x
12. Ding, L., T.L. Saunders, G. Enikolopov, and S.J. Morrison. 2012. Endothelial and perivascular cells maintain haematopoietic stem cells. Nature. 481:457-462. http://dx.doi.org/10.1038/nature10783
13. Dolznig, H., N. Schweifer, C. Puri, N. Kraut, W.J. Rettig, D. Kerjaschki, and P. Garin-Chesa. 2005. Characterization of cancer stroma markers: in silico analysis of an mRNA expression database for fibroblast activation protein and endosialin. Cancer Immun. 5:10.
14. Dvorak, H.F. 1986. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med. 315:1650-1659. http://dx.doi.org/10.1056/NEJM198612253152606
15. Eager, R.M., C.C. Cunningham, N. Senzer, D.A. Richards, R.N. Raju, B. Jones, M. Uprichard, and J. Nemunaitis. 2009a. Phase II trial of talabostat and docetaxel in advanced non-small cell lung cancer. Clin. Oncol. (R. Coll. Radiol.) 21:464-472. http://dx.doi.org/10.1016/j.clon.2009.04.007
16. Eager, R.M., C.C. Cunningham, N.N. Senzer, J. Stephenson Jr., S.P. Anthony, S.J. O'Day, G. Frenette, A.C. Pavlick, B. Jones, M. Uprichard, and J. Nemunaitis. 2009b. Phase II assessment of talabostat and cisplatin in second-line stage IV melanoma. BMC Cancer. 9:263. http://dx.doi.org/10.1186/1471-2407-9-263
17. Evans, W.J., J.E. Morley, J. Argilés, C. Bales, V. Baracos, D. Guttridge, A. Jatoi, K. Kalantar-Zadeh, H. Lochs, G. Mantovani, et al. 2008. Cachexia: a new definition. Clin. Nutr. 27:793-799. http://dx.doi.org/10.1016/j.clnu.2008.06.013
18. Garin-Chesa, P., L.J. Old, and W.J. Rettig. 1990. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc. Natl. Acad. Sci. USA. 87:7235-7239. http://dx.doi.org/10.1073/pnas.87.18.7235
19. Glass, D.J. 2010. Signaling pathways perturbing muscle mass. Curr. Opin. Clin. Nutr. Metab. Care. 13:225-229. http://dx.doi.org/10.1097/MCO.0b013e32833862df
20. Gomes, M.D., S.H. Lecker, R.T. Jagoe, A. Navon, and A.L. Goldberg. 2001. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. Proc. Natl. Acad. Sci. USA. 98:14440-14445. http://dx.doi.org/10.1073/pnas.251541198
21. Hebenstreit, D., M. Fang, M. Gu, V. Charoensawan, A. van Oudenaarden, and S.A. Teichmann. 2011. RNA sequencing reveals two major classes of gene expression levels in metazoan cells. Mol. Syst. Biol. 7:497. http://dx.doi.org/10.1038/msb.2011.28
22. Hebenstreit, D., A. Deonarine, M.M. Babu, and S.A. Teichmann. 2012. Duel of the fates: the role of transcriptional circuits and noise in CD4+ cells. Curr. Opin. Cell Biol. 24:350-358. http://dx.doi.org/10.1016/j.ceb.2012.03.007
23. Hingorani, S.R., L. Wang, A.S. Multani, C. Combs, T.B. Deramaudt, R.H. Hruban, A.K. Rustgi, S. Chang, and D.A. Tuveson. 2005. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell. 7:469-483. http://dx.doi.org/10.1016/j.ccr.2005.04.023
24. Hofheinz, R.D., S.E. al-Batran, F. Hartmann, G. Hartung, D. Jäger, C. Renner, P. Tanswell, U. Kunz, A. Amelsberg, H. Kuthan, and G. Stehle. 2003. Stromal antigen targeting by a humanised monoclonal antibody: an early phase II trial of sibrotuzumab in patients with metastatic colorectal cancer. Onkologie. 26:44-48. http://dx.doi.org/10.1159/000069863
25. Huang, S., R. Fang, J. Xu, S. Qiu, H. Zhang, J. Du, and S. Cai. 2011. Evaluation of the tumor targeting of a FAPα-based doxorubicin prodrug. J. Drug Target. 19:487-496. http://dx.doi.org/10.3109/1061186X.2010.511225
26. Kennedy, G.C. 1950. The hypothalamic control of food intake in rats. Proc. R. Soc. Lond. B Biol. Sci. 137:535-549. http://dx.doi.org/10.1098/rspb.1950.0065
27. Kraman, M., P.J. Bambrough, J.N. Arnold, E.W. Roberts, L. Magiera, J.O. Jones, A. Gopinathan, D.A. Tuveson, and D.T. Fearon. 2010. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science. 330:827-830. http://dx.doi.org/10.1126/science.1195300
28. Langmead, B., and S.L. Salzberg. 2012. Fast gapped-read alignment with Bowtie 2. Nat. Methods. 9:357-359. http://dx.doi.org/10.1038/nmeth.1923
29. LeBeau, A.M., W.N. Brennen, S. Aggarwal, and S.R. Denmeade. 2009. Targeting the cancer stroma with a fibroblast activation protein-activated promelittin protoxin. Mol. Cancer Ther. 8:1378-1386. http://dx.doi.org/10.1158/1535-7163.MCT-08-1170
30. Lee, S.J., and A.C. McPherron. 2001. Regulation of myostatin activity and muscle growth. Proc. Natl. Acad. Sci. USA. 98:9306-9311. http://dx.doi.org/10.1073/pnas.151270098
31. Lee, S.J., L.A. Reed, M.V. Davies, S. Girgenrath, M.E. Goad, K.N. Tomkinson, J.F. Wright, C. Barker, G. Ehrmantraut, J. Holmstrom, et al. 2005. Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc. Natl. Acad. Sci. USA. 102:18117-18122. http://dx.doi.org/10.1073/pnas.0505996102
32. Lee, S.J., Y.S. Lee, T.A. Zimmers, A. Soleimani, M.M. Matzuk, K. Tsuchida, R.D. Cohn, and E.R. Barton. 2010. Regulation of muscle mass by follistatin and activins. Mol. Endocrinol. 24:1998-2008. http://dx.doi.org/10.1210/me.2010-0127
33. Levy, M.T., G.W. McCaughan, C.A. Abbott, J.E. Park, A.M. Cunningham, E. Müller, W.J. Rettig, and M.D. Gorrell. 1999. Fibroblast activation protein: a cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at the tissue remodelling interface in human cirrhosis. Hepatology. 29:1768-1778. http://dx.doi.org/10.1002/hep.510290631
34. Mantovani, G., A. Macciò, L. Mura, E. Massa, M.C. Mudu, C. Mulas, M.R. Lusso, C. Madeddu, and A. Dessì. 2000. Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites. J. Mol. Med. 78:554-561. http://dx.doi.org/10.1007/s001090000137
35. Mauro, A. 1961. Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol. 9:493-495. http://dx.doi.org/10.1083/jcb.9.2.493
36. McFarlane, C., E. Plummer, M. Thomas, A. Hennebry, M. Ashby, N. Ling, H. Smith, M. Sharma, and R. Kambadur. 2006. Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NFkappaB-independent, FoxO1-dependent mechanism. J. Cell. Physiol. 209:501-514. http://dx.doi.org/10.1002/jcp.20757
37. McPherron, A.C., and S.J. Lee. 1997. Double muscling in cattle due to mutations in the myostatin gene. Proc. Natl. Acad. Sci. USA. 94:12457-12461. http://dx.doi.org/10.1073/pnas.94.23.12457
38. Niedermeyer, J., M. Kriz, F. Hilberg, P. Garin-Chesa, U. Bamberger, M.C. Lenter, J. Park, B. Viertel, H. Püschner, M. Mauz, et al. 2000. Targeted disruption of mouse fibroblast activation protein. Mol. Cell. Biol. 20:1089-1094. http://dx.doi.org/10.1128/MCB.20.3.1089-1094.2000
39. Niedermeyer, J., P. Garin-Chesa, M. Kriz, F. Hilberg, E. Mueller, U. Bamberger, W.J. Rettig, and A. Schnapp. 2001. Expression of the fibroblast activation protein during mouse embryo development. Int. J. Dev. Biol. 45:445-447.
40. Omatsu, Y., T. Sugiyama, H. Kohara, G. Kondoh, N. Fujii, K. Kohno, and T. Nagasawa. 2010. The essential functions of adipo-osteogenic progenitors as the hematopoietic stem and progenitor cell niche. Immunity. 33:387-399. http://dx.doi.org/10.1016/j.immuni.2010.08.017
41. Park, J.E., M.C. Lenter, R.N. Zimmermann, P. Garin-Chesa, L.J. Old, and W.J. Rettig. 1999. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J. Biol. Chem. 274:36505-36512. http://dx.doi.org/10.1074/jbc.274.51.36505
42. Peinado, H., S. Lavotshkin, and D. Lyden. 2011. The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin. Cancer Biol. 21:139-146. http://dx.doi.org/10.1016/j.semcancer.2011.01.002
43. Rettig, W.J., P.G. Chesa, H.R. Beresford, H.J. Feickert, M.T. Jennings, J. Cohen, H.F. Oettgen, and L.J. Old. 1986. Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets. Cancer Res. 46:6406-6412.
44. Sandri, M., C. Sandri, A. Gilbert, C. Skurk, E. Calabria, A. Picard, K. Walsh, S. Schiaffino, S.H. Lecker, and A.L. Goldberg. 2004. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell. 117:399-412. http://dx.doi.org/10.1016/S0092-8674(04)00400-3
45. Santos, A.M., J. Jung, N. Aziz, J.L. Kissil, and E. Puré. 2009. Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice. J. Clin. Invest. 119:3613-3625. http://dx.doi.org/10.1172/JCI38988
46. Scott, A.M., G. Wiseman, S. Welt, A. Adjei, F.T. Lee, W. Hopkins, C.R. Divgi, L.H. Hanson, P. Mitchell, D.N. Gansen, et al. 2003. A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin. Cancer Res. 9:1639-1647.
47. Spivak, J.L. 2005. The anaemia of cancer: death by a thousand cuts. Nat. Rev. Cancer. 5:543-555. http://dx.doi.org/10.1038/nrc1648
48. Szymczak, A.L., C.J. Workman, Y. Wang, K.M. Vignali, S. Dilioglou, E.F. Vanin, and D.A. Vignali. 2004. Correction of multi-gene deficiency in vivo using a single 'self-cleaving' 2A peptide-based retroviral vector. Nat. Biotechnol. 22:589-594. http://dx.doi.org/10.1038/nbt957
49. Tanaka, Y., H. Eda, T. Tanaka, T. Udagawa, T. Ishikawa, I. Horii, H. Ishitsuka, T. Kataoka, and T. Taguchi. 1990. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Res. 50:2290-2295.
50. Tisdale, M.J. 2009. Mechanisms of cancer cachexia. Physiol. Rev. 89:381-410. http://dx.doi.org/10.1152/physrev.00016.2008
51. Trapnell, C., B.A. Williams, G. Pertea, A. Mortazavi, G. Kwan, M.J. van Baren, S.L. Salzberg, B.J. Wold, and L. Pachter. 2010. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28:511-515. http://dx.doi.org/10.1038/nbt.1621
52. Wei, G., B.J. Abraham, R. Yagi, R. Jothi, K. Cui, S. Sharma, L. Narlikar, D.L. Northrup, Q. Tang, W.E. Paul, et al. 2011. Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. Immunity. 35:299-311. http://dx.doi.org/10.1016/j.immuni.2011.08.007
53. Wiedenmann, B., P. Malfertheiner, H. Friess, P. Ritch, J. Arseneau, G. Mantovani, F. Caprioni, E. Van Cutsem, D. Richel, M. DeWitte, et al. 2008. A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia. J. Support. Oncol. 6:18-25.
54. Zhou, X., J.L. Wang, J. Lu, Y. Song, K.S. Kwak, Q. Jiao, R. Rosenfeld, Q. Chen, T. Boone, W.S. Simonet, et al. 2010. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell. 142:531-543. http://dx.doi.org/10.1016/j.cell.2010.07.011
55. Zimmers, T.A., M.V. Davies, L.G. Koniaris, P. Haynes, A.F. Esquela, K.N. Tomkinson, A.C. McPherron, N.M. Wolfman, and S.J. Lee. 2002. Induction of cachexia in mice by systemically administered myostatin. Science. 296:1486-1488. http://dx.doi.org/10.1126/science.1069525